Investment
Features
FeesSafety
Academy
More
Pluang+

Compare McKesson Corporation (MCK) vs Ryanair Holdings plc (RYAAY) Price & Performance

McKesson CorporationTrade
Ryanair Holdings plcTrade

Price performance (Past 24H)

Key statistics

McKesson Corporation vs Ryanair Holdings plc — how do they compare? McKesson Corporation trades at $824.07 (market cap $97.35B), while Ryanair Holdings plc trades at $59.3 (market cap $29.31B). The key difference: McKesson Corporation is far larger — about 3.3× Ryanair Holdings plc's market cap, and Ryanair Holdings plc pays the higher dividend (1.68%). Which is the better fit depends on your goals.

MCKRYAAY
Market Cap
$97.35B$29.31B
Sector
HealthIndustrials
52-Week High
$995.69$73.82
52-Week Low
$659.01$53.24
Enterprise Value
$101.98B$26.33B
Dividend Yield
0.39%1.68%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

McKesson Corporation

McKesson Corporation (MCK) trades at $831.60, down 1.16% on the day, with a bullish technical signal and positive earnings momentum after beating estimates for three consecutive quarters. The stock shows strong analyst support with an 80% buy rating and a consensus price target of $932.83, implying potential upside. Revenue growth is robust, reaching $359.05 billion in 2025, though net margins remain thin at 1.18%. Cash flow from operations improved to $6.09 billion in 2025, supporting financial stability.

The outlook for MCK is positive, driven by earnings beats, analyst optimism, and solid cash generation. Key opportunities include growth in specialty pharma and oncology services. Risks involve policy uncertainties, competitive pressures, and execution challenges. The stock's current price near key support at $829 suggests a critical level for near-term direction.

Ryanair Holdings plc

RYAAY is trading at $58.91, down 5.85% amid broader airline sector weakness. The stock shows mixed signals with bearish technical indicators but solid fundamentals including a 13.45 P/E ratio and 13.98% net income margin. Recent Q1 2026 earnings beat expectations despite a 34% profit decline due to lower fares and higher fuel costs. Analyst consensus remains positive with 62.5% buy ratings, though technical analysis suggests near-term pressure.

RYAAY presents a value opportunity with attractive valuation metrics and strong profitability, but faces headwinds from fuel cost volatility and fare pressure. The airline's cost leadership and traffic growth provide resilience, though geopolitical risks and seasonal weakness warrant caution. Wall Street's bullish stance contrasts with current technical weakness, creating potential for recovery once sector sentiment improves.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About McKesson Corporation

McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.

Read more on MCK

About Ryanair Holdings plc

Ryanair is the leading airline group by passenger numbers in Europe. The company employs a low-cost no-frills model to offer low fares to leisure customers on short-haul intra-European routes. In 2020, the most recent pre-pandemic fiscal year, the company carried 149 million passengers, utilizing a fleet of 467 Boeing 737 aircraft across its 1,800 routes. To keep costs low the company serves predominantly lower-cost secondary airports. The company generated sales of EUR 8.5 billion in fiscal 2020.

Read more on RYAAY